The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals ME Falagas, A Zarkali, DE Karageorgopoulos, V Bardakas, MN Mavros PloS one 8 (2), e49476, 2013 | 187 | 2013 |
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression NP Oxtoby, LA Leyland, LM Aksman, GEC Thomas, EL Bunting, ... Brain 144 (3), 975-988, 2021 | 85 | 2021 |
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease GEC Thomas, A Zarkali, M Ryten, K Shmueli, AL Gil-Martinez, LA Leyland, ... Brain 144 (6), 1787-1798, 2021 | 78 | 2021 |
Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction A Zarkali, P McColgan, LA Leyland, AJ Lees, G Rees, RS Weil Neurology 94 (14), e1525-e1538, 2020 | 67 | 2020 |
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease A Zarkali, P McColgan, LA Leyland, AJ Lees, G Rees, RS Weil Communications biology 4 (1), 86, 2021 | 63 | 2021 |
Increased weighting on prior knowledge in Lewy body-associated visual hallucinations A Zarkali, RA Adams, S Psarras, LA Leyland, G Rees, RS Weil Brain communications 1 (1), fcz007, 2019 | 60 | 2019 |
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease A Zarkali, P McColgan, LA Leyland, AJ Lees, RS Weil Movement Disorders 36 (5), 1191-1202, 2021 | 50 | 2021 |
Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease A Zarkali, P McColgan, M Ryten, R Reynolds, LA Leyland, AJ Lees, ... Brain 143 (11), 3435-3448, 2020 | 46 | 2020 |
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease A Zarkali, P McColgan, LA Leyland, AJ Lees, RS Weil Journal of Neurology, Neurosurgery & Psychiatry 93 (2), 169-179, 2022 | 27 | 2022 |
Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson’s disease GEC Thomas, P Zeidman, T Sultana, A Zarkali, A Razi, RS Weil Brain Communications 5 (1), fcac329, 2023 | 26 | 2023 |
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis A Zarkali, O Cousins, D Athauda, S Moses, N Moran, S Harikrishnan Practical Neurology 18 (4), 315-319, 2018 | 24 | 2018 |
CD8+ encephalitis: a severe but treatable HIV-related acute encephalopathy A Zarkali, N Gorgoraptis, R Miller, L John, A Merve, S Thust, R Jager, ... Practical neurology 17 (1), 42-46, 2017 | 23 | 2017 |
Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease N Hannaway, A Zarkali, LA Leyland, F Bremner, JM Nicholas, SK Wagner, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (9), 742-750, 2023 | 21 | 2023 |
Atrial fibrillation: an underestimated cause of ischemic monocular visual loss? A Zarkali, SF Cheng, A Dados, R Simister, A Chandratheva Journal of Stroke and Cerebrovascular Diseases 28 (6), 1495-1499, 2019 | 20 | 2019 |
Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease A Zarkali, AI Luppi, EA Stamatakis, S Reeves, P McColgan, LA Leyland, ... Communications Biology 5 (1), 928, 2022 | 17 | 2022 |
Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature A Zarkali, DE Karageorgopoulos, PI Rafailidis, ME Falagas Current medical research and opinion 30 (3), 471-480, 2014 | 14 | 2014 |
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration C Estevez-Fraga, A Altmann, CS Parker, RI Scahill, B Costa, Z Chen, ... Brain 146 (11), 4532-4546, 2023 | 13 | 2023 |
Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression R Bhome, A Zarkali, GEC Thomas, JE Iglesias, JH Cole, RS Weil npj Parkinson's Disease 8 (1), 2, 2022 | 13 | 2022 |
Trainees leading quality improvement A Zarkali, F Acquaah, F Donaghy A trainee doctor’s perspective on incorporating quality improvement in …, 2016 | 13 | 2016 |
Dementia risk in Parkinson’s disease is associated with interhemispheric connectivity loss and determined by regional gene expression A Zarkali, P McColgan, M Ryten, RH Reynolds, LA Leyland, AJ Lees, ... NeuroImage: Clinical 28, 102470, 2020 | 12 | 2020 |